Town Hall: Exploring Massachusetts’ Opportunities for Sustainable Expansion of the Life Sciences

May 11, 2021 11:00 AM - 11:30 AM

Webinar, click "live-stream" button to view

Add to Calendar 5/11/2021 11:00:00 AM 5/11/2021 11:30:00 AM Town Hall: Exploring Massachusetts’ Opportunities for Sustainable Expansion of the Life Sciences

Like the companies it supports, the Massachusetts life sciences industry must continue to innovate in order to remain the leader in the global biopharma ecosystem. As the industry looks to the “next normal,” Massachusetts has a unique opportunity to grow vertically by expanding its leadership beyond R&D and horizontally by expanding the ecosystem beyond the Cambridge/Boston cluster.

During our May Town Hall, panelists will discuss how Massachusetts can build a stronger, more sustainable biopharma cluster through expansion-focused economic development.
 

NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.

 Webinar, click "live-stream" button to view
Vice President, Discovery Biotherapeutics, Bristol Myers Squibb
Sharon Cload is Vice President, Discovery Biotherapeutics, at Bristol Myers Squibb (BMS) where her team works in partnership with the Immunology, Cardiovascular, and Fibrosis (ICF) and Mechanisms of Cancer Resistance (MoCR) Thematic Research Centers. Sharon joined BMS in 2008 at the Adnexus Therapeutics site in Waltham, and led the evolution of their core biologics discovery platforms. She was part of the team that launched BMS’ new research site in Kendall Square in 2018. Sharon has enjoyed being part of the vibrant Cambridge life sciences ecosystem in both biotech and pharma settings throughout her career. Prior to BMS, she held roles leading discovery teams at Archemix Corp. and Scriptgen Pharmaceuticals. She is passionate about cultivating relationships within the entrepreneurial community enable science that will benefit patients. Sharon was a post-doctoral fellow with Peter Schultz at the University of California, Berkeley and earned her Ph.D. in Bio-Organic Chemistry with Alanna Schepartz at Yale University. She is currently a member of the MassBio Board of Directors.